Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Approved for marketing
×
Triple Negative Breast Neoplasms
×
Clear all
Filters
2
NCT04320693
2021-08-19
Expanded Access for IMMU-132
Gilead Sciences
Approved for marketing